drugset / Trial / NCT04404439

Treatment of Tinnitus With Migraine Medications

NCT04404439

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Tinnitus represents one of the most common and distressing otologic problems, and it causes various somatic and psychological disorders that interfere with the quality of life. In addition, it contributes significant costs to the healthcare system. However, the mechanisms of tinnitus are poorly understood. and there is currently no FDA-approved medication to treat this condition. Current pharmacological treatment options address the stress, anxiety, and depression that are caused by tinnitus. There is an increased evidence of an epidemiological and mechanistic association between tinnitus and migraine. Therefore, in this study, we intended to evaluate the effectiveness of two combinations of migraine medications on patients with moderate to severe tinnitus by comparing them to placebo.

Timeline

Start
2019-09-26
Primary completion
2023-12-30
Completion
2023-12-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Nortriptyline Small molecule 60 mg
Subject Paroxetine Small molecule 32 mg
Subject Topiramate Small molecule 80 mg
Subject Verapamil Other / unclassified 240 mg

Indications